简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
acquisition
LENDLEASE GLOBAL COMMERCIAL TRUST MANAGEMENT PTE. LTD. Acquires the Remaining 30% Stake in PLQ Mall to Achieve 100% Ownership
Tags:
LENDLEASE GLOBAL COMMERCIAL TRUST MANAGEMENT PTE. LTD.
acquisition
2026-02-25
CASA HOLDINGS LIMITED Announces Proposed Acquisition of 80% Equity in POLYBUILDING (S) PTE. LTD. for S$13.2 Million
Tags:
CASA HOLDINGS LIMITED
acquisition
POLYBUILDING (S)
2026-02-12
GRAB Announces Acquisition of U.S. Digital Investing Platform Stash to Accelerate Global Financial Services Expansion
Tags:
GRAB HOLDINGS LIMITED
acquisition
Stash
2026-02-12
ANTA Sports(02020.HK): To Purchase 29.06% of PUMA for RMB 12.28 Billion, Advancing "Single-Focus, Multi-Brand and Globalization" Strategy
Tags:
ANTA SPORTS
02020.HK
acquisition
2026-01-27
Ferretti (09638.HK): Receives Partial Tender Offer from Controlling Shareholder, Proposing to Acquire up to 15.4% of Shares at €3.50 per Share
Tags:
Ferretti
09638.HK
acquisition
2026-01-19
Bank of Zhengzhou(06196.HK): Regulatory Approval Obtained for Acquisition of Junxian and Yanling Rural Banks
Tags:
Bank of Zhengzhou
06196.HK
acquisition
2026-01-06
Previous
1
2
Featured News
Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea
Finance
Overseas Chinese Town Asia (03366.HK): 100% Equity Interest in Huizhou Project Put Up for Public Listing Sale, Winning Bid Price at Approximately RMB 307 Million
Finance
Sino Biopharmaceutical (01177.HK): TRD205 (AT2R Antagonist) Included in CDE’s Breakthrough Therapy Designation List
Finance
Weigao Group(01066.HK): Controlling Shareholder Adds Approximately 15.5988 Million H Shares, Cumulative Share Purchase Hits Around 30.55 Million Shares
Scan QR Code
Download App